Vitamin D and COVID-19: What Doctors Know (and Don't Know)

New Post Public Reply Private Reply Replies (1) Message Board
toodles
383
Vitamin D and COVID-19: What Doctors Know (and Don't Know) So Far
Research continues into whether supplements can prevent or treat coronavirus infections

In the early days of the pandemic, when health care workers were struggling to treat patients who poured into emergency rooms sick with COVID-19, a 2017 study landed in David Meltzer's inbox that gave him an idea. It found that people who took vitamin D were less likely to have a viral respiratory tract infection.

"At that point, we had nothing” to treat COVID-19, says Meltzer, M.D., chief of the Section of Hospital Medicine at the University of Chicago. “We didn't have dexamethasone [a steroid now used to help counter inflammation caused by a coronavirus infection] — we truly had nothing. So I thought, Wow, this is worth looking into.”

In the last year, Meltzer has published two studies exploring vitamin D and its potential impact on COVID-19 risk — and he's not the only one. Several others have investigated vitamin D as a tool for COVID-19 prevention or treatment, and around 50 studies on the subject are currently active or recruiting participants, according to the government's registry of clinical trials.

Why is there such interest in vitamin D?
There are a few reasons researchers have zeroed in on vitamin D, which is perhaps best known for its bone-health benefits. For starters, it plays an important role in immune function and helps keep inflammation in check. And “one of the problems” with COVID-19, Meltzer says, is that some people's immune systems go into overdrive, “and you get inflammation in the lungs and shortness of breath, and all that sort of stuff.”

Plus, vitamin D deficiency is relatively common, especially among certain populations, including people with dark skin, older adults, individuals who are homebound or in nursing homes, and obese people — all groups that have been hit hard by the coronavirus.

Another reason for the interest: “In reasonable doses,” vitamin D is safe for most people, explains Robert Shmerling, M.D., senior editor at Harvard Health Publishing and corresponding faculty at Harvard Medical School. Plus it's pretty easy to find. Vitamin D is naturally present in some foods, including salmon and cheese. It can also be obtained through sunlight and supplements.

Where to get vitamin D
Sunlight: 5 to 30 minutes of sun exposure at least twice a week
Supplements (600 to 800 international units a day)
Fatty fish such as trout, salmon, tuna and mackerel
Cheese
Egg yolks
Mushrooms
Fortified foods, including cereal, milk and orange juice
Source: NIH

The recommended daily amount of vitamin D is at least 600 international units (IUs) for people ages 19 to 70 and at least 800 IUs for those older than 70, according to the National Institutes of Health (NIH). It's important to keep in mind that too much vitamin D can cause serious health complications. The NIH sets the tolerable upper intake for adults at 4,000 IUs per day.

What does the science say so far about vitamin D?
Several studies have shown an association between low vitamin D levels and increased risk for COVID-19, though not a direct link. A paper published in September 2020 from Meltzer and his colleagues found that people who were vitamin D-deficient were more likely to test positive for COVID-19. A more recent study from Meltzer noted that Black individuals who have higher levels of vitamin D were less likely to test positive for COVID-19 than people with sufficient levels.

Researchers in Spain reported in August 2020 that a form of vitamin D called calcifediol reduced intensive care admissions among patients with COVID-19. However, a 2020 study conducted in Brazil concluded that a single high dose of vitamin D did not affect disease severity.

a a r p membership card
Save 25% when you join AARP and enroll in Automatic Renewal for first year. Get instant access to discounts, programs, services, and the information you need to benefit every area of your life.

Shmerling's advice? “Stand by.” There's not enough scientific evidence right now to prove that vitamin D is helpful in preventing or treating COVID-19, but it's possible we'll get data out of the 50-some ongoing studies “and learn more about who really benefits from extra vitamin D and who doesn't,” he adds.
In the meantime, both experts say there's no downside to taking a supplement or multivitamin that contains the recommended amount of vitamin D — especially if you're concerned you don't get enough through your diet or sunlight. But it's always a good idea to consult a doctor first, especially if you are on other medications.

"There's a lot we don't understand about the biology of this,” Meltzer says. “But in the absence of that, there are some very safe things we can do, like take low-level daily vitamin D supplements and get some sun.”

Meltzer is also a proponent of study participation, and he's currently enrolling adults, including those who have been vaccinated, for two randomized controlled trials to test whether vitamin D supplements can reduce the risk and severity of COVID-19.

What has been proven to prevent and treat COVID?
So far only one drug, remdesivir, has been approved by the Food and Drug Administration (FDA) for the treatment of COVID-19, and several monoclonal antibodies have been authorized under emergency use. Health care providers may also administer other therapies, including antiviral medications, blood thinners and steroids, to help minimize damage from the virus in hospitalized patients.

When it comes to illness prevention, three vaccines — from Moderna, Pfizer-BioNTech and Johnson & Johnson — have cleared FDA authorization. And the Centers for Disease Control and Prevention (CDC) recommends everyday efforts, such as wearing a mask in public and avoiding crowds, to help keep people from getting sick. Experts also stress the importance of a healthy diet for disease prevention, since chronic health conditions associated with poor nutrition and lack of physical activity increase a person's risk for more severe outcomes from a coronavirus infection.

Beyond Vitamin D: What About Zinc, Vitamin C, Melatonin and Pepcid?
While vitamin D is the most studied supplement surrounding COVID-19, it isn't the only one. Researchers are also looking into whether vitamin C (an antioxidant with anti-inflammatory properties) and zinc (a mineral also important in immune health) hold any power over the coronavirus. For example, one registered trial will look at the impact intravenous vitamin C has on COVID-19 disease severity; another will study whether combination therapies —


TOODLES

1
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 431

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Brixton Metals Delivers Promising Drill Results in Thorn Project

Updated Category News Views 167

Brixton Metals' Latest Drill Results Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) recently unveiled its second batch of drill results from the 2025 exploration season. The company operates the Thorn Project, an underexplored district known for its potential in copper-gold porphyry deposits. Highlighting Impressive Assay Results The recent drilling at the...

Continue Reading
US Labor Market Stagnation: A Closer Look at 2025 Trends

Updated Category News Views 275

November Layoffs and Hiring Trends In November, layoffs by U.S. employers reduced significantly, signaling a shift in the job market dynamics. Yet, companies are still hesitant to recruit new employees, indicating a labor market that remains restrained due to various pressures. Businesses are facing challenges such as soft demand, tariff implications, and soaring...

Continue Reading
Dollar Steady Amid Global Market Uncertainty and Yuan Weakness

Updated Category News Views 127

Asian Currency Markets React to U.S. Dollar Strength In the bustling arena of Asian currencies, the atmosphere is charged with anticipation as investors monitor the situation in China regarding potential economic stimulus measures. Meanwhile, the U.S. dollar is exhibiting remarkable strength, currently hovering near a two-and-a-half month high. This rise comes in light of...

Continue Reading
Understanding Recent Insider Trades at Omega Healthcare Invts

Updated Category News Views 75

Examining Insider Trades at Omega Healthcare Invts Recently, a notable insider trade involving Omega Healthcare Invts has drawn attention. Chief Operating Officer Daniel Booth executed a significant transaction, selling 56,725 shares as disclosed through an SEC filing. This particular sale took place on a recent date and revealed a total transaction value of $2,283,181....

Continue Reading
Exploring Future Growth in Healthcare Digital Payments Market

Updated Category News Views 150

Introduction to Digital Payments in Healthcare The transformation in the realm of healthcare is not just about treatments and services; it extends deeply into how payments are managed. The Digital Payment in Healthcare Market is evolving, with an anticipated growth in value reaching USD 61,521.8 Million by the year 2033. This incredible increase is projected to occur at a...

Continue Reading